Physical therapy and NLRP3-related ICU-acquired muscle weakness
Official title: Effect of Physical Therapy on NLRP3 Inflammasome Activation and Muscle Atrophy in Critical Illness Myopathy (PT-NLRP3-CIM).
Run by University of Chile · NCT07017517 · Data updated 2026-11-12
This study will test whether enhanced physical therapy using servo-assisted bed cycling can reduce NLRP3 inflammasome activation and muscle wasting in critically ill patients at risk of critical illness myopathy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of Chile Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 3 sites (Santiago, Metropolitan Region and 2 other locations) |
| Status | Recruiting |
| Started | April 20, 2026 |
| Main results expected | May 2027 |
| Study ends | May 2027 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT07017517 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with sepsis admitted to the ICU who are invasively mechanically ventilated and expected to require ventilation for ≥7 days with sustained high SOFA scores in the early ICU period.
✕Probably not a fit
Patients with pre-existing neuromuscular disease, severe coagulopathy or thrombocytopenia, imminent death, expected ICU stay under seven days, or other listed exclusions are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional study will assign critically ill, septic patients expected to require prolonged mechanical ventilation to either enhanced physical therapy with Motomed Letto® servo-assisted bed cycling plus standard physiotherapy or to standard physiotherapy alone during the early ICU stay. Researchers will measure markers of NLRP3 inflammasome activation and atrogene expression alongside clinical indicators of muscle degradation and function. The trial focuses on patients with high organ failure scores who are at elevated risk for ICU-acquired weakness, and compares molecular and clinical outcomes between the two physical therapy approaches. The aim is to determine whether early, intensified mobilization reduces inflammatory signaling in skeletal muscle and limits atrophy.
Why it matters
Potential benefit: If successful, the intervention could lessen muscle atrophy, shorten recovery time, and improve functional outcomes after critical illness.
How similar studies have gone: Preclinical animal studies link NLRP3 inflammasome activation to muscle atrophy and show that exercise or early mobilization can reduce inflammasome markers, but direct clinical evidence for servo-assisted cycling reducing NLRP3 activation in ICU patients is limited and relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Medical diagnosis of sepsis upon ICU admission. * Receiving invasive mechanical ventilation with a projected requirement ≥7 days. * SOFA score ≥8 for three consecutive days within the first five days of ICU admission. Exclusion Criteria: * Neurocritical illness. * Prior malnutrition or cachexia. * Pre-existing neuromuscular disease. * Coagulopathy (severe liver disease or continuous dialysis). * Thrombocytopenia \<20,000 platelets/μL. * Prior Clinical Frailty Scale ≥4. * Lower limb amputation or fractures. * Ongoing chemotherapy. * Pregnancy. * BMI \>35. * Uncontrolled epilepsy. * Allergy to ultrasound gel. * Prior prolonged corticosteroid therapy. * Expected ICU stay \<7 days. * Imminent death. * Legal guardian refusal to provide informed consent.
Where it's running
-
Clínica INDISA
Santiago, Metropolitan Region, Chile Recruiting -
Hospital de Urgencia Asistencia Pública (HUAP)
Santiago, Metropolitan Region, Chile Recruiting -
University of Chile
Santiago, Metropolitan Region, Chile Recruiting
Study contacts
- Study coordinator: Óscar L Arellano-Pérez, MSc.
- Email: oscar.arellano@ug.uchile.cl
- Phone: +56961479414
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Critical-illness–related muscle and nerve weakness in adults hospitalized outside the ICU
This project will test how often adults hospitalized with acute illness outside the ICU develop severe muscle and nerve weakness by comparing patients with organ failure to those without.
-
High-tech rehabilitation program for adults with acute neuromuscular disease
This trial will test whether a high-tech rehab program using robotics, virtual reality, and balance platforms helps adults with acute neuromuscular conditions improve balance, strength, fatigue, and quality of life more than usual therapy.
-
Improving walking recovery in patients with muscle weakness from critical illness
This study is testing if using electrical stimulation during rehabilitation can help critically ill patients with muscle weakness walk better and recover faster.
-
Study on muscle weakness after surgery in intensive care patients
This study is testing if changes in blood and muscle samples from surgical patients can help us understand and find markers for muscle weakness that happens after being in intensive care.
-
Observing recovery from weakness after severe respiratory and cardiac failure
This study looks at how people who had severe breathing and heart problems recover from weakness after being in intensive care and on a special life-support machine, to see what helps or hinders their recovery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.